GlassScriptPhysician profile
David H Schaer
NPI 1205892809
$75,205.55
in general payments reported to CMS, 2019-2025
26 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $8,079 · 2021: $20K · 2022: $22K · 2023: $4,521 · 2024: $8,865 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $1,793 · Travel and Lodging: $80.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,865.00 |
| Food and Beverage | $1,792.76 |
| Travel and Lodging | $80.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $69,013.66 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $3,341.93 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $583.94 | 2019-2025 | |
| Abiomed | $519.91 | 2019-2025 | Impella |
| Abbott Laboratories | $332.90 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $212.20 | 2019-2025 | Watchman Flx |
| Cvrx, INC. | $177.42 | 2021 | |
| Medtronic, INC. | $166.21 | 2024 | Symplicity G3, Onyx Frontier |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2025 | Wainua |
| Philips North America LLC | $112.85 | 2019 | |
| Merck Sharp & Dohme LLC | $102.82 | 2022-2023 | Verquvo |
| Cardiva Medical, INC. | $89.37 | 2023 | Cardiva Vascade 6/7f Vcs |
| Amgen INC. | $82.95 | 2019-2023 | Repatha |
| Gilead Sciences, INC. | $66.82 | 2019 | |
| Arbor Pharmaceuticals, INC. | $48.67 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $32.40 | 2022-2024 | |
| Kiniksa Pharmaceuticals, LTD. | $28.91 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $27.21 | 2019-2021 | |
| Atricure, INC. | $24.61 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.55 | 2024 | Lifevest |
| Heartflow, INC. | $19.92 | 2025 | |
| Tactile Systems Technology INC | $16.11 | 2020 | |
| Daiichi Sankyo INC. | $15.18 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.95 | 2022 | |
| Alnylam Pharmaceuticals INC. | $14.58 | 2022 | |
| Amarin Pharma, INC. | $14.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schaer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.